These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1201173)

  • 1. Proceedings: Plasma concentrations of pancuronium bromide (pavulon) in patients with normal and impaired renal function.
    McLeod K; Watson MJ; Rawlins MD
    Br J Anaesth; 1975 Aug; 47(8):902-3. PubMed ID: 1201173
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of pancuronium in patients with normal and impaired renal function.
    McLeod K; Watson MJ; Rawlins MD
    Br J Anaesth; 1976 Apr; 48(4):341-5. PubMed ID: 1276000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of Pavulon in renal insufficiency patients].
    Tornos Solano D
    Rev Esp Anestesiol Reanim; 1974 Jan; 21(1):61-7. PubMed ID: 4594967
    [No Abstract]   [Full Text] [Related]  

  • 4. Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure.
    Bencini AF; Scaf AH; Sohn YJ; Meistelman C; Lienhart A; Kersten UW; Schwarz S; Agoston S
    Anesth Analg; 1986 Mar; 65(3):245-51. PubMed ID: 2869722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Pancuronium bromide (Pavulon, Organon). A new non-depolarizing neuromuscular blocker.
    Ezi-Ashi TI
    West Afr J Pharmacol Drug Res; 1975 Jun; 2(1):79P. PubMed ID: 1226750
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma binding of pancuronium: effects of age, sex, and disease.
    Wood M; Stone WJ; Wood AJ
    Anesth Analg; 1983 Jan; 62(1):29-32. PubMed ID: 6849508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in anesthetized children.
    Meistelman C; Agoston S; Kersten UW; Saint-Maurice C; Bencini AF; Loose JP
    Anesth Analg; 1986 Dec; 65(12):1319-23. PubMed ID: 2877596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of nifedipine in patients with renal failure.
    Bogaert MG; Rosseel MT; Joos R; Boelaert J
    Arzneimittelforschung; 1984; 34(3):307-8. PubMed ID: 6539611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma human brain natriuretic peptide in chronic renal failure.
    Akiba T; Tachibana K; Togashi K; Hiroe M; Marumo F
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S61-4. PubMed ID: 8608666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
    Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
    J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic study of pyrazinamide and pyrazinoic acid in subjects with normal renal function and patients with renal failure].
    Vayre P; Chambraud E; Fredj G; Thuillier A
    Therapie; 1989; 44(1):1-4. PubMed ID: 2734715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of succinylcholine on serum potassium concentration in children with chronic renal failure].
    Kotani T; Nishio I; Kou H; Suzuki G; Fukushima K; Noguchi I
    Masui; 1993 Jan; 42(1):20-4. PubMed ID: 8433488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pavulon (pancuronium bromide).
    Huffman M
    Crit Care Nurse; 1982; 2(4):4, 9. PubMed ID: 6925515
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma homocysteine in renal failure.
    Hultberg B; Andersson A; Sterner G
    Clin Nephrol; 1993 Oct; 40(4):230-5. PubMed ID: 8261681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.
    Sohn YJ; Bencini AF; Scaf AH; Kersten UW; Agoston S
    Anesth Analg; 1986 Mar; 65(3):233-9. PubMed ID: 2869721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Falsely elevated plasma aldosterone concentration by direct radioimmunoassay in chronic renal failure.
    Koshida H; Miyamori I; Miyazaki R; Tofuku Y; Takeda R
    J Lab Clin Med; 1989 Sep; 114(3):294-300. PubMed ID: 2769019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma guanylin levels in patients with impaired renal function.
    Kinoshita H; Nakazato M; Yamaguchi H; Matsukura S; Fujimoto S; Eto T
    Clin Nephrol; 1997 Jan; 47(1):28-32. PubMed ID: 9021238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified method for the fluorimetric determination of pancuronium bromide in plasma.
    Watson JM; McLeod K
    Clin Chim Acta; 1977 Sep; 79(2):511-2. PubMed ID: 890986
    [No Abstract]   [Full Text] [Related]  

  • 19. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma amino acid patterns in normal Thais and in patients with chronic renal failure.
    Suvanapha R; Tungsanga K; Laorpatanaskul S; Sitprija V; Suwan S
    J Med Assoc Thai; 1991 Apr; 74(4):211-7. PubMed ID: 1940707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.